<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether the <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> response to <z:hpo ids='HP_0001824'>weight loss</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> can be improved by modifying the macronutrient composition of the commonly prescribed low-fat, high-carbohydrate (<z:chebi fb="0" ids="29327">CHO</z:chebi>) hypocaloric diet </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Nine <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were treated with a <z:chebi fb="0" ids="25413">monounsaturated fatty acid</z:chebi> (MUFA)-enriched weight-reducing formula diet and compared with eight <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> treated with a low-fat, high-<z:chebi fb="0" ids="29327">CHO</z:chebi> weight-reducing formula diet </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001824'>Weight loss</z:hpo> ensued for 6 weeks, followed by 4 weeks of refeeding using isocaloric formulas enriched with MUFA or <z:chebi fb="0" ids="29327">CHO</z:chebi>, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Fasting blood samples were obtained to measure plasma <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> susceptibility to oxidation (measured as lag time: time required to induce in vitro formation of conjugated dienes) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: At baseline, there were no differences between the groups in plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, or <z:chebi fb="15" ids="39026">LDL</z:chebi> susceptibility to oxidation </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001824'>Weight loss</z:hpo> was similar between the groups </plain></SENT>
<SENT sid="6" pm="."><plain>Dieting resulted in decreases in total plasma cholesterol, <z:chebi fb="15" ids="39026">LDL</z:chebi>, <z:chebi fb="17" ids="39025">HDL</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> A and B (P &lt; 0.05), but the MUFA group manifested a greater decrease in total cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B and a smaller decrease in <z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A than the <z:chebi fb="0" ids="29327">CHO</z:chebi> group (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Improvements in these parameters were sustained during refeeding </plain></SENT>
<SENT sid="8" pm="."><plain>After dieting, lag time was prolonged in the MUFA group (208 +/- 10 min) compared with the <z:chebi fb="0" ids="29327">CHO</z:chebi> group (146 +/- 11 min; P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Lag time was prolonged further during refeeding in the MUFA group (221 +/- 13 min, P = 0.10), while the <z:chebi fb="0" ids="29327">CHO</z:chebi> group remained unchanged (152 +/- 9 min, P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Lag time correlated strongly with the <z:chebi fb="0" ids="16196">oleic acid</z:chebi> content of <z:chebi fb="15" ids="39026">LDL</z:chebi> after dieting and refeeding (r = 0.74 and r = 0.93, respectively; both P &lt; 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Macronutrient content is an important determinant of the <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> response to <z:hpo ids='HP_0001824'>weight loss</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>MUFA-enriched hypocaloric diets potentiate the beneficial effects of <z:hpo ids='HP_0001824'>weight loss</z:hpo> to ameliorate <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> in <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>